Central regions | Technology & innovation

Moscow State University develops new thyroid gland cancer drug

16 Oct '13
A research team at Lomonosov Moscow State University (MSU) is developing an innovation y-tracer called Astat-211 to fight thyroid gland cancer, announced MSUs Skobeltsyn Institute of Nuclear Physics, the prime driver of the new project.

The research effort is being pushed by a scientific team led by Prof. O. A. Yuminov.

The new y-tracer is based on the 211-At radioactive nuclide, believed to be a powerful anti-tumor weapon, and is expected to be more efficient in cancer therapies while substantially decreasing radiation doses for patients and medical staff, compared to the conventional y-tracers currently using the 131-I nuclide. Unlike the future y-tracer, the 131-I is a source of β- and γ-rays that possess a considerable penetrating powerup to a few centimeters in biological tissues. This results in exposing patients to a relatively large dose of healthy organ irradiation, while the destruction of cancerous cells is far from efficient.

The 211-At radioactive nuclide emits high-energy α-particles that only penetrate about 50-70 microns of biological tissues, just a few diameters of a cell. So, if the drug is delivered close to an organ bearing a malignant tumor, its cancerous cells that will predominantly be destroyed.

In preliminary experiments the Skobeltsyn Institute team found out that being a chemical analog of the 131-I, the 211-At is capable of selectively accumulating in the thyroid gland and participating in this organs metabolic processes.

The 211-Ats above properties are expected to pave the way for its broad use in thyroid gland cancer therapies.

The 211-At is an artificial isotope unavailable in nature. At the moment, the MSU Skobeltsyn Institute researchers are conducting preclinical trials of the new Astat-211 y-tracer.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations: Moscow

Tags: cancer (63) / MSU (38) / y tracer (1) / thyroid gland (1) / Astat 211 (0) /

Latest News: Central regions
20 Feb '18 | Finance, business | Transport, logistics
16 Feb '18 | Finance, business | Technology & innovation
14 Feb '18 | Telecoms, media | Technology & innovation
8 Feb '18 | Technology & innovation
7 Feb '18 | Finance, business | Technology & innovation
 

Feature stories

21 Nov '17
Russian scientists have come up with what they say is...
7 Sep '17
26 Jul '17
Scientists at Tomsk Polytechnic (TPU) in Siberia have...
Search (News archive - 21211)
Advertising
Independent Software Developers Forum
Advertising
Marchmont News

Latest News

20 Feb '18
Yandex, the NASDAQ-listed Russian search giant, and...
19 Feb '18
Scientists in Vladivostok, in Russias Far East, have...
16 Feb '18
Hemopharm, a Russian biotech company, is developing a...

Most read stories from last week

19 Feb '18
Scientists in Vladivostok, in Russias Far East, have...
20 Feb '18
Yandex, the NASDAQ-listed Russian search giant, and...